PolTREG S.A. is a biotechnology company founded in 2015. The company is headquartered in Gdansk and has a Research and Development Center located there as well. The company's mission is to develop effective therapies for autoimmune diseases based on T-regulatory cells (TREG). PolTREG has four advanced projects in clinical trials focused on type 1 diabetes and multiple sclerosis. Additionally, the company has projects involving next-generation genetically modified T-regulatory lymphocytes in its portfolio.
Headquarters
ul. Botaniczna 20
Gdansk; Pomorskie;
Postal Code: 80-298
Contact Details: Purchase the Poltreg S.A. report to view the information.
Website: http://www.poltreg.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service